Outreach Recovery II, LLC
Outreach Recovery II, LLC was paid $20.11M by Medicaid between Apr 2019 and Dec 2024, across 20 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 49% of everything it billed.
LAUREL, MD 20707
Next to other Addiction (Substance Use Disorder) Counselor providers in Maryland
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Paid by month
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 5,631 | $363K | |
| 2020 | 42,863 | $2.71M | |
| 2021 | 64,082 | $5.25M | |
| 2022 | 68,815 | $5.50M | |
| 2023 | 51,728 | $3.39M | |
| 2024incomplete | 42,994 | $2.89M |
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 49% | 92,415 | 66,542 | $9.81M |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 32% | 139,510 | 96,722 | $6.42M |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed | 7.0% | 16,577 | 13,429 | $1.40M |
| 90836 | 2.0% | 4,092 | 2,959 | $406K | |
| 90792 | Psychiatric diagnostic evaluation with medical services | 1.7% | 756 | 734 | $335K |
| 90833 | Psychotherapy, 30 minutes with patient when performed with an E&M service (add-on) | 1.6% | 4,600 | 2,921 | $322K |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 1.5% | 2,641 | 2,003 | $292K |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 8-14 drug class(es), including metabolite(s) if performed | 1.2% | 1,967 | 1,412 | $251K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 1.1% | 2,799 | 2,414 | $224K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | <1% | 1,021 | 864 | $159K |
| 90791 | Psychiatric diagnostic evaluationPsychiatric diagnostic evaluation | <1% | 1,117 | 1,090 | $139K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 4,716 | 3,068 | $118K |
8 more codes
| 99205 | Prolong outpt/office vis | <1% | 635 | $112K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 955 | $43K |
| 90853 | Group psychotherapy (other than of a multiple-family group) | <1% | 1,110 | $29K |
| 99441 | <1% | 420 | $11K | |
| 90838 | <1% | 230 | $9K | |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 236 | $8K |
| 90832 | Psychotherapy session, about 30 minutes | <1% | 299 | $6K |
| 90837 | Psychotherapy session, about an hour | <1% | 17 | $695.20 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
Who's on the registration
| Provider | Location | Paid |
|---|---|---|
| Bhmat Consulting LLC | Catonsville, MD | $2.10M |
| Outreach Recovery II, LLC | Cumberland, MD | $1.87M |
| Outreach Recovery II, LLC | Cumberland, MD | $1.01M |
| Outreach Recovery II, LLC | Waldorf, MD | $908K |
| Outreach Recovery II | Annapolis, MD | $802K |
| Outreach Recovery II, LLC | Glen Burnie, MD | $686K |
| Outreach Recovery II, LLC | Hagerstown, MD | $619K |
| Outreach Recovery II, LLC | Frederick, MD | $618K |
| Outreach Recovery II | Great Mills, MD | $412K |
| Outreach Recovery II, LLC | Waldorf, MD | $229K |
| Outreach Recovery II | Baltimore, MD | $228K |
| Outreach Recovery II | Easton, MD | $215K |
| Outreach Recovery II, LLC | Hagerstown, MD | $173K |
| Outreach Recovery II | Catonsville, MD | $98K |
| Outreach Recovery II, LLC | Lexington Park, MD | $4K |
| Outreach Recovery II, LLC | Baltimore, MD | $2K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.